U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C14H18ClN2O2.Cl
Molecular Weight 317.211
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of (4-(M-CHLOROPHENYLCARBAMOYLOXY)-2-BUTYNYL)TRIMETHYLAMMONIUM CHLORIDE

SMILES

[Cl-].C[N+](C)(C)CC#CCOC(=O)NC1=CC=CC(Cl)=C1

InChI

InChIKey=CXFZFEJJLNLOTA-UHFFFAOYSA-N
InChI=1S/C14H17ClN2O2.ClH/c1-17(2,3)9-4-5-10-19-14(18)16-13-8-6-7-12(15)11-13;/h6-8,11H,9-10H2,1-3H3;1H

HIDE SMILES / InChI
4-(M-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium (McN-A-343) is a selective muscarinic M1 receptors agonist, which leads to its widespread use as an aid to distinguish responses mediated through M₁ receptors from those utilizing M₂ or M₃ muscarinic receptor subtypes, especially in the CNS. McN-A-343 has a number of non-muscarinic actions. These include activation of some types of nicotinic acetylcholine receptors, antagonism of serotonin 5-HT₃ and 5-HT₄ receptor subtypes, inhibition of the uptake mechanism and a local anesthetic action.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: P11229
Gene ID: 1128.0
Gene Symbol: CHRM1
Target Organism: Homo sapiens (Human)
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
PubMed

PubMed

TitleDatePubMed
McN-A-343, a specific agonist of M1-muscarinic receptors, exerts antinicotinic and antimuscarinic effects in the rat adrenal medulla.
1986 Dec 1
Functional determination of McN-A-343 affinity for M1 muscarinic receptors.
1990 Apr
Investigating the interaction of McN-A-343 with the M2 muscarinic receptor using its nitrogen mustard derivative.
2010 Apr 1
The pharmacology of McN-A-343.
2012 Aug
Patents

Patents

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
The selective M1-receptor agonist McN-A-343 ((4-(M-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium ) (100μM) induced a current similar to the CCh-activated current in sinus rhythm atrial cardiomyocytes pretreated with pertussis toxin to inhibit M2-receptor-mediated Gi-protein signaling, which was abolished by MT-7.
Name Type Language
(4-(M-CHLOROPHENYLCARBAMOYLOXY)-2-BUTYNYL)TRIMETHYLAMMONIUM CHLORIDE
Systematic Name English
2-BUTYN-1-AMINIUM, 4-((((3-CHLOROPHENYL)AMINO)CARBONYL)OXY)-N,N,N-TRIMETHYL-, CHLORIDE
Systematic Name English
MCN-A-343-11
Code English
MCN-343
Code English
2-BUTYN-1-AMINIUM, 4-((((3-CHLOROPHENYL)AMINO)CARBONYL)OXY)-N,N,N-TRIMETHYL-, CHLORIDE (1:1)
Systematic Name English
4-(M-CHLOROPHENYLCARBAMOYLOXY)-2-BUTYNYLTRIMETHYLAMMONIUM CHLORI
Common Name English
MCN-A-343
Code English
A-343
Code English
(4-HYDROXY-2-BUTYNYL)TRIMETHYLAMMONIUM CHLORIDE, M-CHLOROCARBANILATE
Common Name English
4-(M-CHLOROPHENYLCARBAMOYLOXY)-2-BUTYNYL)TRIMETHYLAMMONIUM CHLORIDE
Common Name English
AMMONIUM, (4-HYDROXY-2-BUTYNYL)TRIMETHYL-, CHLORIDE, M-CHLOROCARBANILATE
Common Name English
Code System Code Type Description
FDA UNII
CW55R761RE
Created by admin on Sat Dec 16 04:41:32 GMT 2023 , Edited by admin on Sat Dec 16 04:41:32 GMT 2023
PRIMARY
PUBCHEM
5926
Created by admin on Sat Dec 16 04:41:32 GMT 2023 , Edited by admin on Sat Dec 16 04:41:32 GMT 2023
PRIMARY
CAS
55-45-8
Created by admin on Sat Dec 16 04:41:32 GMT 2023 , Edited by admin on Sat Dec 16 04:41:32 GMT 2023
PRIMARY
EPA CompTox
DTXSID80203532
Created by admin on Sat Dec 16 04:41:32 GMT 2023 , Edited by admin on Sat Dec 16 04:41:32 GMT 2023
PRIMARY